Skip to main content
Top
Published in: Inflammation 1-2/2007

01-04-2007

Relation Between Plasma oxLDL Antibodies and oxLDL in the Circulation

Authors: Yan Wang, Xueqiang Fang, Shumei Wang, Yueqiu Feng, Jinghai Yin

Published in: Inflammation | Issue 1-2/2007

Login to get access

Objectives

To investigate the possible relationship between circulating oxLDL and oxLDL Ab concentrations in order to better understand the role of oxLDL Ab in atherosclerosis.

Design

In a cross-sectional study of 86 patients undergoing ultrasonographic scanning of the carotid artery, concentration of circulating oxLDL and oxLDL Ab were determined by ELISA. For multivariate analysis, we also measured many conventional cardiovascular risk factors. Spearman’s rank correlation test and chi-square test were used to evaluate the correlation between circulating oxLDL and oxLDL Ab. A stepwise multiple regression analysis and Logistic regression analysis were used to study the influencing factors.

Results

There was no linear correlation between circulating oxLDL and oxLDL Ab. Circulating oxLDL was influenced by HDL, systolic blood pressure and body mass index, while only TC was independent factor associating with oxLDL Ab.

Conclusions

The present study showed that oxLDL was present at a low concentration in the circulation, and that plasma oxLDL had no linear correlation with oxLDL antibodies. However, the issue still needs further study.
Literature
1.
go back to reference Fang, J. C., S. Kinlay, and D. Behrendt. 2002. Circulating autoantibodies to oxidized LDL correlate with impaired coronary endothelial function after cardiac transplantation. Arterioscler. Thromb. Vasc. Biol. 22:2044–2048.PubMedCrossRef Fang, J. C., S. Kinlay, and D. Behrendt. 2002. Circulating autoantibodies to oxidized LDL correlate with impaired coronary endothelial function after cardiac transplantation. Arterioscler. Thromb. Vasc. Biol. 22:2044–2048.PubMedCrossRef
2.
go back to reference Fukumoto, M., T. Shoji, and M. Emoto. 2000. Antibodies against oxidized LDL and carotid artery intima-media thickness in a healthy population. Arterioscler. Thromb. Vasc. Biol. 20:703–707.PubMed Fukumoto, M., T. Shoji, and M. Emoto. 2000. Antibodies against oxidized LDL and carotid artery intima-media thickness in a healthy population. Arterioscler. Thromb. Vasc. Biol. 20:703–707.PubMed
3.
go back to reference Yasunobu, Y., K. Hayashi, and T. Shingu. 2001. Coronary atherosclerosis and oxidative stress as reflected by autoantibodies against oxidized low-density lipoprotein and oxysterols. Atherosclerosis 155:453–455.CrossRef Yasunobu, Y., K. Hayashi, and T. Shingu. 2001. Coronary atherosclerosis and oxidative stress as reflected by autoantibodies against oxidized low-density lipoprotein and oxysterols. Atherosclerosis 155:453–455.CrossRef
4.
go back to reference Steinberg, D., S. Parthasarathy, and T. E. Carew. 1989. Beyond cholesterol: modification of low density lipoprotein that increase its atherogenicity. N. Engl. J. Med. 320:915–924.PubMedCrossRef Steinberg, D., S. Parthasarathy, and T. E. Carew. 1989. Beyond cholesterol: modification of low density lipoprotein that increase its atherogenicity. N. Engl. J. Med. 320:915–924.PubMedCrossRef
5.
go back to reference Tornvall, P., G. Waeg, and J. Nilsson. 2003. Autoantibodies against modified low-density lipoproteins in coronary artery disease. Atherosclerosis 167:347–353.PubMedCrossRef Tornvall, P., G. Waeg, and J. Nilsson. 2003. Autoantibodies against modified low-density lipoproteins in coronary artery disease. Atherosclerosis 167:347–353.PubMedCrossRef
6.
go back to reference Sakai, M., A. Miyazaki, and H. Hakamata. 1994. Lysophosphatidylcholine plays an essential role in the mitogenic effect of oxidized low density lipoprotein on murine macrophages. J. Biol. Chem. 269:31430–31435.PubMed Sakai, M., A. Miyazaki, and H. Hakamata. 1994. Lysophosphatidylcholine plays an essential role in the mitogenic effect of oxidized low density lipoprotein on murine macrophages. J. Biol. Chem. 269:31430–31435.PubMed
7.
go back to reference Görög, P. 1997. Modified low-density lipoprotein is a potent stimulus for smooth muscle cell outgrowth from rat aortic explant in vitro. Atherosclerosis 129:1–7.PubMedCrossRef Görög, P. 1997. Modified low-density lipoprotein is a potent stimulus for smooth muscle cell outgrowth from rat aortic explant in vitro. Atherosclerosis 129:1–7.PubMedCrossRef
8.
go back to reference Björkerud, B., and S. Björkerud. 1996. Contrary effects of lightly and strongly oxidized LDL with potent promotion of growth versus apoptosis on arterial smooth muscle cells, macrophages, and fibroblasts. Arterioscler. Thromb. Vasc. Biol. 16:416–424.PubMed Björkerud, B., and S. Björkerud. 1996. Contrary effects of lightly and strongly oxidized LDL with potent promotion of growth versus apoptosis on arterial smooth muscle cells, macrophages, and fibroblasts. Arterioscler. Thromb. Vasc. Biol. 16:416–424.PubMed
9.
go back to reference Esterbauer, H., J. Gebicki, and H. Puhl. 1992. The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Radic. Biol. Med. 13:341–390.PubMedCrossRef Esterbauer, H., J. Gebicki, and H. Puhl. 1992. The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Radic. Biol. Med. 13:341–390.PubMedCrossRef
10.
go back to reference Maggi, E., R. Chiesa, and G. Melissano. 1994. LDL oxidation in patients with severe carotid atherosclerosis: a study of in vitro and in vivo oxidation markers. Arterioscler. Thromb. 14:1892–1899.PubMed Maggi, E., R. Chiesa, and G. Melissano. 1994. LDL oxidation in patients with severe carotid atherosclerosis: a study of in vitro and in vivo oxidation markers. Arterioscler. Thromb. 14:1892–1899.PubMed
11.
go back to reference Puurunen, M., M. Manttari, and V. Manninen. 1994. Antibody against oxidized low-density lipoprotein predicting myocardial infarction. Arch. Intern. Med. 154:2605–2609.PubMedCrossRef Puurunen, M., M. Manttari, and V. Manninen. 1994. Antibody against oxidized low-density lipoprotein predicting myocardial infarction. Arch. Intern. Med. 154:2605–2609.PubMedCrossRef
12.
go back to reference Bergmark, C., R. Wu, and U. de Faire. 1995. Patients with early-onset peripheral vascular disease have increased levels of autoantibodies against oxidized LDL. Arterioscler. Thromb. Vasc. Biol. 15:441–445.PubMed Bergmark, C., R. Wu, and U. de Faire. 1995. Patients with early-onset peripheral vascular disease have increased levels of autoantibodies against oxidized LDL. Arterioscler. Thromb. Vasc. Biol. 15:441–445.PubMed
13.
go back to reference Maggi, E., G. Finardi, and M. Poli. 1993. Specificity of autoantibodies against oxidized LDL as an additional marker for atherosclerotic risk. Coron. Artery. Dis. 4:1119–1122.PubMedCrossRef Maggi, E., G. Finardi, and M. Poli. 1993. Specificity of autoantibodies against oxidized LDL as an additional marker for atherosclerotic risk. Coron. Artery. Dis. 4:1119–1122.PubMedCrossRef
14.
go back to reference Marchesi, E., A. Martignoni, and M. Salvini. 1996. Carotid intima-media thickening and in vivo LDL oxidation in patients with essential hypertension. J. Hum. Hypertens. 10(9):577–582(Sept.).PubMed Marchesi, E., A. Martignoni, and M. Salvini. 1996. Carotid intima-media thickening and in vivo LDL oxidation in patients with essential hypertension. J. Hum. Hypertens. 10(9):577–582(Sept.).PubMed
15.
go back to reference Salonen, J. T., S. Yla-Herttuala, and R. Yamamoto. 1992. Autoantibodies against oxidized LDL and progression of carotid atherosclerosis. Lancet 339:883–887.PubMedCrossRef Salonen, J. T., S. Yla-Herttuala, and R. Yamamoto. 1992. Autoantibodies against oxidized LDL and progression of carotid atherosclerosis. Lancet 339:883–887.PubMedCrossRef
16.
go back to reference Rossi, G. P., M. Cesari, and R. De Toni. 2003. Antibodies to oxidized low-density lipoproteins and angiographically assessed coronary artery disease in white patients. Circulation 108:2467–2472.PubMedCrossRef Rossi, G. P., M. Cesari, and R. De Toni. 2003. Antibodies to oxidized low-density lipoproteins and angiographically assessed coronary artery disease in white patients. Circulation 108:2467–2472.PubMedCrossRef
17.
go back to reference Cherubini, A., P. Mecocci, and U. Senin. 1997. Autoantibodies against oxidized lowdensity lipoproteins in older stroke patients. J. Am. Geriatr. Soc. 45:125.PubMed Cherubini, A., P. Mecocci, and U. Senin. 1997. Autoantibodies against oxidized lowdensity lipoproteins in older stroke patients. J. Am. Geriatr. Soc. 45:125.PubMed
18.
go back to reference Schumacher, M., B. Eber, and F. Tatzber. 1995. Transient reduction of autoantibodies against oxidized LDL in patients with acute myocardial infarction. Free Radic. Biol. Med. 18:1087–1091.PubMedCrossRef Schumacher, M., B. Eber, and F. Tatzber. 1995. Transient reduction of autoantibodies against oxidized LDL in patients with acute myocardial infarction. Free Radic. Biol. Med. 18:1087–1091.PubMedCrossRef
19.
go back to reference Wu, R., U. de Faire, and C. Lemne. 1999. Autoantibodies to oxLDL are decreased in individuals with borderline hypertension. Hypertension 33:53–59.PubMed Wu, R., U. de Faire, and C. Lemne. 1999. Autoantibodies to oxLDL are decreased in individuals with borderline hypertension. Hypertension 33:53–59.PubMed
20.
go back to reference Matti, M., I. J. Uusitupa, L. Niskanen, and J. Luoma. 1996. Autoantibodies against oxidized LDL do not predict atherosclerotic vascular disease in non-insulin-dependent diabetes. Arterioscler. Thromb. Vasc. Biol. 16:1236–1242. Matti, M., I. J. Uusitupa, L. Niskanen, and J. Luoma. 1996. Autoantibodies against oxidized LDL do not predict atherosclerotic vascular disease in non-insulin-dependent diabetes. Arterioscler. Thromb. Vasc. Biol. 16:1236–1242.
21.
go back to reference Shoji, T., Y. Nishizawa, and M. Fukumoto. 2000. Inverse relationship between circulating oxidized low density lipoprotein (oxLDL) and anti-oxLDL antibody levels in healthy subjects. Atherosclerosis 148:171–177.PubMedCrossRef Shoji, T., Y. Nishizawa, and M. Fukumoto. 2000. Inverse relationship between circulating oxidized low density lipoprotein (oxLDL) and anti-oxLDL antibody levels in healthy subjects. Atherosclerosis 148:171–177.PubMedCrossRef
22.
go back to reference Holvoet, P., G. Theilmeier, and B. Shivalkar. 1998. LDL hypercholesterolemia is associated with accumulation of oxidized LDL, atherosclerotic plaque growth, and compensatory vessel enlargement in coronary arteries of miniature pigs. Arterioscler. Thromb. Vasc. Biol. 18:415–422.PubMed Holvoet, P., G. Theilmeier, and B. Shivalkar. 1998. LDL hypercholesterolemia is associated with accumulation of oxidized LDL, atherosclerotic plaque growth, and compensatory vessel enlargement in coronary arteries of miniature pigs. Arterioscler. Thromb. Vasc. Biol. 18:415–422.PubMed
23.
go back to reference Holvoet, P., J. Van Cleemput, and De′sire′ Collen. 2000. Oxidized low density lipoprotein is a prognostic marker of transplant-associated coronary artery disease. Arterioscler. Thromb. Vasc. Biol. 20:698–702.PubMed Holvoet, P., J. Van Cleemput, and De′sire′ Collen. 2000. Oxidized low density lipoprotein is a prognostic marker of transplant-associated coronary artery disease. Arterioscler. Thromb. Vasc. Biol. 20:698–702.PubMed
24.
go back to reference Itabe, H., H. Yamamoto, and T. Imanaka. 1996. Sensitive detection of oxidatively modified low density lipoprotein using a monoclonal antibody. J. Lipid. Res. 37:45–53.PubMed Itabe, H., H. Yamamoto, and T. Imanaka. 1996. Sensitive detection of oxidatively modified low density lipoprotein using a monoclonal antibody. J. Lipid. Res. 37:45–53.PubMed
25.
go back to reference Tsimikas, S., W. Palinski, and J. L. Witztum. 2001. Circulating autoantibodies to oxidized LDL correlate with arterial accumulation and depletion of oxidized LDL in LDL receptor-deficient mice. Arterioscler. Thromb. Vasc. Biol. 21:95–100.PubMed Tsimikas, S., W. Palinski, and J. L. Witztum. 2001. Circulating autoantibodies to oxidized LDL correlate with arterial accumulation and depletion of oxidized LDL in LDL receptor-deficient mice. Arterioscler. Thromb. Vasc. Biol. 21:95–100.PubMed
26.
go back to reference Tsimikas, S., J. L.Witztum. 2001. Measuring circulating oxidized low-density lipoprotein to evaluate coronary risk. Circulation 103:1930–1932.PubMed Tsimikas, S., J. L.Witztum. 2001. Measuring circulating oxidized low-density lipoprotein to evaluate coronary risk. Circulation 103:1930–1932.PubMed
27.
go back to reference Holvoet, P., Jean-Marie Stassen, and J. Van Cleemput. 1998. Oxidized low density lipoproteins in patients with transplant-associated coronary artery disease. Arterioscler. Thromb. Vasc. Biol. 18:100–107.PubMed Holvoet, P., Jean-Marie Stassen, and J. Van Cleemput. 1998. Oxidized low density lipoproteins in patients with transplant-associated coronary artery disease. Arterioscler. Thromb. Vasc. Biol. 18:100–107.PubMed
28.
go back to reference O’Brien, K. D., C. E. Alpers, and J. E. Hokanson. 1996. Oxidation-specific epitopes in human coronary atherosclerosis are not limited to oxidized low-density lipoprotein. Circulation 94:1216–1225.PubMed O’Brien, K. D., C. E. Alpers, and J. E. Hokanson. 1996. Oxidation-specific epitopes in human coronary atherosclerosis are not limited to oxidized low-density lipoprotein. Circulation 94:1216–1225.PubMed
Metadata
Title
Relation Between Plasma oxLDL Antibodies and oxLDL in the Circulation
Authors
Yan Wang
Xueqiang Fang
Shumei Wang
Yueqiu Feng
Jinghai Yin
Publication date
01-04-2007
Published in
Inflammation / Issue 1-2/2007
Print ISSN: 0360-3997
Electronic ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-006-9016-9

Other articles of this Issue 1-2/2007

Inflammation 1-2/2007 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.